Kartik Krishnan
CIK: 0002131061
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KTTA
Pasithea Therapeutics Corp.
Officer
Discretionary Trading P&L
Holdings
About Krishnan Kartik
Krishnan Kartik (SEC CIK 0002131061) files insider reports with the SEC as Chief Medical Officer of Pasithea Therapeutics Corp. (KTTA).
Signal8 holds 2 ownership filings by Krishnan Kartik (1 Form 3, 1 Form 4), filed on May 5, 2026. Those filings report 1 transaction, the latest on May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Krishnan Kartik's filings is in MIAMI BEACH, FL.
Recent filings by Krishnan Kartik
- May 1, 2026: Grant or award of KTTA derivative securities (Form 4, code A).
Other insiders filing for Pasithea Therapeutics Corp. (KTTA)
- Coastlands Capital LP, 10% Owner
- Marques Tiago, Chief Executive Officer
- STEINMAN LAWRENCE, Director
- Dumesnil Simon, Director
- Schneiderman Daniel H, Chief Financial Officer
- Leahy Emer, Director